Method for simultaneously detecting various impurities in rafenasin solution for inhalation
A liquid chromatography method effectively detects multiple impurities in revefenacin solution for inhalation with high specificity and accuracy, addressing the lack of simultaneous detection in prior art by achieving peak separation and recovery within specified ranges.
Patent Information
- Application Number
- CN202411380918.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-30
- Publication Date
- 2024-12-31
AI Technical Summary
There is no method in the prior art that can simultaneously detect multiple impurities (A, B, C, D, E, and F) in revefenacin solution for inhalation with high accuracy and specificity.
A method using liquid chromatography with specific conditions (Agilent EC-C18 column, mobile phases A and B, flow rate, injection volume, and detection wavelength) to detect impurities A, B, C, D, E, and F in revefenacin solution for inhalation.
The method achieves good specificity with peak separation greater than 1.5, linear relationship of impurity concentrations, and recovery rates between 80% to 120% with RSD less than 10%, ensuring accurate detection of multiple impurities.
Smart Images

Figure CN119224180A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of drug analysis, and in particular relates to a method for simultaneously detecting multiple impurities in a refenacin solution for inhalation. Background Art
[0002] Revefenacin solution for inhalation is a long-acting sarcosine antagonist. In the airway, it exhibits pharmacological effects by inhibiting smooth muscle M3 receptors to cause bronchial dilation. Inhaled preparations can directly enter the pulmonary capillaries, take effect quickly, and avoid the first-pass effect of the liver. It is currently the main dosage form for the prevention and treatment of acute and chronic respiratory diseases worldwide. Revefenacin solution for inhalation is mainly used to treat chronic obstructive pulmonary disease.
[0003] In the production process of raw materials in the production process of refenacin, the impurities that may be introduced into the raw materials include impurity A, impurity B, impurity C, impurity D, impurity E, and impurity F. Among them, impurity B, impurity C, impurity D, and impurity E are both process impurities and degradation impurities. Among them, impurity A and impurity F are the main degradation impurities. It is considered that all known impurities in the raw materials will be studied in the refenacin solution for inhalation. There is no method in the prior art that can simultaneously detect multiple impurities in the refenacin solution for inhalation. Summary of the invention
[0004] In view of this, the object of the present invention is to provide a method for simultaneously detecting multiple impurities in a refenacin solution for inhalation, which can simultaneously detect impurities A, impurity B, impurity C, impurity D, impurity E, and impurity F in the refenacin solution for inhalation. The method is fast and simple and has good accuracy, specificity and linearity.
[0005] In order to achieve the above object, the present invention provides the following technical solutions:
[0006] A method for simultaneously detecting multiple impurities in a refenacin solution for inhalation, wherein impurity A, impurity B, impurity C, impurity D, impurity E, and impurity F in the refenacin solution for inhalation are detected by liquid chromatography;
[0007] The structural formulas of the impurities are as follows:
[0008]
[0009]
[0010] The liquid chromatography detection conditions are as follows: the chromatographic column is Agilent EC-C18, 4.6×100 mm, 2.7 μm; the mobile phase A is a phosphate buffer solution of 0.02 mol / l, and the mobile phase B is a mixed solution of acetonitrile-methanol with a volume ratio of 90:10; the flow rate is 1.0 ml per minute; the injection volume is 50 μl; the detection wavelength is 205 nm; the column temperature is 30°C; and the linear gradient elution is performed according to the following table:
[0011]
[0012] As a preferred technical solution, the preparation method of the mobile phase A 0.02 mol / l phosphate buffer solution is: take 2.72 g of potassium dihydrogen phosphate and 9.2 g of potassium hexafluorophosphate, add water to dissolve and dilute to 1000 ml, and adjust the pH value to 5.0 with potassium hydroxide solution.
[0013] As a preferred technical solution, for the test solution: take the product and inject it directly; for the control solution: accurately measure 0.5 ml of the test solution, put it in a 100 ml volumetric flask, add solvent to dilute to the scale, shake well, and obtain; the test solution and the control solution are tested using the liquid chromatography detection conditions.
[0014] The beneficial effects of the present invention are:
[0015] The liquid chromatography provided by the invention can simultaneously detect impurities A, B, C, D, E and F in a refenacin solution for inhalation, the separation between peaks of the detection spectrum is greater than 1.5, and the method has good specificity; the concentration of each impurity presents a good linear relationship with the peak area, and the linearity of the method is good; the recovery rate of each impurity is in the range of 80% to 120%, the RSD is less than 10%, and the method has good accuracy. BRIEF DESCRIPTION OF THE DRAWINGS
[0016] In order to make the purpose, technical solution and beneficial effects of the present invention clearer, the present invention provides the following drawings for illustration:
[0017] Figure 1 Locate the solution test spectrum for impurity A;
[0018] Figure 2 Locate the solution test spectrum for impurity B;
[0019] Figure 3 Locate the solution test spectrum for impurity C;
[0020] Figure 4 Locate the solution test spectrum for impurity D;
[0021] Figure 5 Locate the solution test spectrum for impurity E;
[0022] Figure 6 Locate the solution test spectrum for impurity F;
[0023] Figure 7 This is the system suitability solution test spectrum;
[0024] Figure 8 is the linear graph of impurity D;
[0025] Fig. 9 is the linear graph of impurity F;
[0026] Fig.10 is the linear graph of impurity A;
[0027] Fig.11 is the linear graph of impurity E;
[0028] Fig.12 is the linear graph of impurity C;
[0029] Fig.13 It is the linear graph of refenacin;
[0030] Fig.14 It is the linear graph of impurity B. DETAILED DESCRIPTION
[0031] The present invention is further described below in conjunction with the accompanying drawings and specific embodiments so that those skilled in the art can better understand the present invention and implement it, but the embodiments are not intended to limit the present invention.
[0032] Example 1 Specificity
[0033] (1) Preparation of impurity A stock solution: Take about 10 mg of impurity A, accurately weigh it, place it in a 100 ml volumetric flask, add 1 ml of methanol to dissolve it, dilute it to the scale with solvent, and shake well.
[0034] (2) Impurity B stock solution: Take about 10 mg of impurity B, weigh it accurately, place it in a 100 ml volumetric flask, add 1 ml of methanol to dissolve it and dilute it to the scale with solvent, shake well, and obtain the solution.
[0035] (3) Impurity C stock solution: Take about 10 mg of impurity C, weigh it accurately, place it in a 100 ml volumetric flask, add 1 ml of methanol to dissolve it and dilute it to the scale with solvent, shake well, and obtain the solution.
[0036] (4) Impurity D stock solution: Take about 10 mg of impurity D, weigh accurately, place in a 100 ml volumetric flask, add 1 ml of methanol to dissolve, dilute to the mark with solvent, shake well, and obtain.
[0037] (5) Stock solution of impurity E: Take about 10 mg of impurity E, weigh it accurately, place it in a 100 ml volumetric flask, add 1 ml of methanol to dissolve it, dilute it to the mark with solvent, shake well, and obtain the solution.
[0038] (6) Impurity F stock solution: Take about 10 mg of impurity F, weigh accurately, place in a 100 ml volumetric flask, add 1 ml of methanol to dissolve it and dilute to the scale with solvent, shake well, and obtain.
[0039] (7) Stock solution of refenacin: Take about 10 mg of refenacin reference substance, weigh accurately, place in a 100 ml volumetric flask, add 1 ml of methanol to dissolve, dilute to the mark with solvent, shake well, and obtain.
[0040] (8) Impurity localization solution: Take 0.6 ml of each impurity stock solution and place it in a 100 ml volumetric flask, add solvent to dilute to the scale, shake well, and obtain (each impurity localization solution).
[0041] (9) Preparation of mixed solution: Accurately measure 3 ml of each of the stock solutions of impurity A, impurity B, impurity C, impurity D, impurity E, impurity F, and refenacin stock solution and place them in a 100 ml volumetric flask, add solvent to dilute to the mark, take 1 ml and place it in a 10 ml volumetric flask, add solvent to dilute to the mark, shake well, and obtain the mixed solution.
[0042] (10) Liquid chromatography detection:
[0043] The liquid chromatography detection conditions are as follows: the chromatographic column is Agilent EC-C18, 4.6×100 mm, 2.7 μm; the mobile phase A is 0.02 mol / l phosphate buffer solution (2.72 g of potassium dihydrogen phosphate and 9.2 g of potassium hexafluorophosphate are dissolved in water and diluted to 1000 ml, and the pH value is adjusted to 5.0 with potassium hydroxide solution), and the mobile phase B is acetonitrile-methanol (volume ratio 90:10); the flow rate is 1.0 ml per minute; the injection volume is 50 μl; the detection wavelength is 205 nm; the column temperature is 30° C.; linear gradient elution is performed according to the following table:
[0044]
[0045]
[0046] The detection spectra of each impurity obtained in Example 1 are as follows Figure 1-Figure 6 As shown, the peak order of the mixed solution is impurity D, impurity F, impurity A, impurity E, impurity C, refenacin, impurity B (such as Figure 7 The specific results are shown in Table 1:
[0047] Table 1 Retention time of each substance in the detection spectrum obtained in Example 1 and the separation degree between substances
[0048] Substance name Retention time (min) Separation Impurity D 6.019 / Impurity F 10.352 17.31 Impurity A 10.992 2.38 Impurity E 13.650 9.94 Impurity C 18.391 16.08 Refenacin 20.702 6.31 Impurity B 25.303 12.48
[0049] According to the above test results, the liquid chromatography method provided by the present invention can simultaneously detect impurities A, B, C, D, E and F in the refenacin solution for inhalation, and the separation between the peaks of the detection spectrum is greater than 1.5, and the method has good specificity.
[0050] Example 2 Linearity Test
[0051] The liquid chromatography detection conditions provided in Example 1 were used to examine the linearity of each impurity content limit within the range of 4.4% to 200%.
[0052] 1. Prepare linear solution:
[0053] (1) Blank solution: solvent: mobile phase A-mobile phase B (68:32).
[0054] (2) Impurity A stock solution: Take about 10 mg of impurity A, weigh accurately, place in a 100 ml volumetric flask, add 1 ml of methanol to dissolve, dilute to the mark with solvent, shake well, and obtain (100 μg / ml).
[0055] (3) Impurity B stock solution: Take about 10 mg of impurity B, weigh accurately, place in a 100 ml volumetric flask, add 1 ml of methanol to dissolve, dilute to the mark with solvent, shake well, and obtain (100 μg / ml).
[0056] (4) Impurity C stock solution: Take about 10 mg of impurity C, weigh accurately, place in a 100 ml volumetric flask, add 1 ml of methanol to dissolve, dilute to the scale with solvent, shake well, and obtain (100 μg / ml).
[0057] (5) Impurity D stock solution: Take about 10 mg of impurity D, weigh accurately, place in a 100 ml volumetric flask, add 1 ml of methanol to dissolve, dilute to the mark with solvent, shake well, and obtain (100 μg / ml).
[0058] (6) Stock solution of impurity E: Take about 10 mg of impurity E, weigh accurately, place in a 100 ml volumetric flask, add 1 ml of methanol to dissolve, dilute to the mark with solvent, shake well, and obtain (100 μg / ml).
[0059] (7) Impurity F stock solution: Take about 10 mg of impurity F, weigh accurately, place in a 100 ml volumetric flask, add 1 ml of methanol to dissolve it and dilute to the scale with solvent, shake well, and obtain (100 μg / ml).
[0060] (8) Stock solution of revenacin: Take about 10 mg of revenacin reference substance, weigh accurately, place in a 100 ml volumetric flask, add 1 ml of methanol to dissolve, dilute to the mark with solvent, shake well, and obtain (100 μg / ml).
[0061] (9) Linear stock solution: Accurately measure 3 ml each of impurity A, impurity B, impurity C, impurity D, impurity E, impurity F stock solution, and refenacin stock solution, place in a 100 ml volumetric flask, add diluent to dilute to the scale, shake well, and obtain (each 1 ml of solution contains approximately 3 μg each of impurity A, impurity B, impurity C, impurity D, impurity E, impurity F, and refenacin).
[0062] (10) Linear solution 1 (4.4%): Accurately measure 3 ml of linear solution 2, place in a 10 ml volumetric flask, dilute to the mark with solvent, and shake well to obtain (each 1 ml of solution contains approximately 0.014 μg each of impurity A, impurity B, impurity C, impurity D, impurity E, impurity F, and refenacin).
[0063] (11) Linear solution 2 (15%): Accurately measure 1.5 ml of the linear stock solution and place it in a 100 ml volumetric flask. Dilute to the mark with solvent and shake well to obtain (each 1 ml of the solution contains approximately 0.045 μg each of impurity A, impurity B, impurity C, impurity D, impurity E, impurity F and refenacin).
[0064] (12) Linear solution 3 (30%): Accurately measure 1.5 ml of the linear stock solution and place it in a 50 ml volumetric flask. Dilute to the mark with solvent and shake well to obtain (each 1 ml of the solution contains approximately 0.09 μg each of impurity A, impurity B, impurity C, impurity D, impurity E, impurity F and refenacin).
[0065] (13) Linear solution 4 (50%): Accurately measure 1 ml of the linear stock solution and place it in a 20 ml volumetric flask. Dilute to the mark with solvent and shake well to obtain (each 1 ml of the solution contains approximately 0.15 μg each of impurity A, impurity B, impurity C, impurity D, impurity E, impurity F and refenacin).
[0066] (14) Linear solution 5 (60%): Accurately measure 1.2 ml of the linear stock solution, place it in a 20 ml volumetric flask, dilute to the mark with solvent, and shake well to obtain (each 1 ml of the solution contains approximately 0.18 μg each of impurity A, impurity B, impurity C, impurity D, impurity E, impurity F, and refenacin).
[0067] (15) Linear solution 6 (100%): Accurately measure 1 ml of the linear stock solution and place it in a 10 ml volumetric flask. Dilute to the mark with solvent and shake well to obtain (each 1 ml of the solution contains approximately 0.3 μg each of impurity A, impurity B, impurity C, impurity D, impurity E, impurity F and refenacin).
[0068] (16) Linear solution 7 (200%): Accurately measure 2 ml of the linear stock solution, place it in a 10 ml volumetric flask, dilute to the mark with solvent, and shake well to obtain (each 1 ml of the solution contains approximately 0.6 μg each of impurity A, impurity B, impurity C, impurity D, impurity E, impurity F, and refenacin).
[0069] 2. The above linear solution was tested using the liquid chromatography test conditions provided in Example 1.
[0070] Impurity D linear equation curve is as follows Figure 8 As shown, the test results and linear equations are shown in Table 2:
[0071] Table 2 Impurity D linear solution test results and linear equation
[0072]
[0073] Impurity F linear equation curve is as follows Fig. 9 As shown, the test results and linear equations are shown in Table 3:
[0074] Table 3 Impurity F linear solution test results and linear equation
[0075]
[0076] The linear equation curve of impurity A is as follows Fig.10 As shown in Table 4, the test results and the linear equation are as follows:
[0077] Table 4 Impurity A linear solution test results and linear equation
[0078]
[0079] Impurity E linear equation curve is as follows Fig.11 As shown, the test results and linear equations are shown in Table 5:
[0080] Table 5 Impurity E linear solution test results and linear equation
[0081]
[0082] Impurity C linear equation curve is as follows Fig.12 As shown, the test results and linear equations are shown in Table 6:
[0083] Table 6 Impurity C linear solution test results and linear equation
[0084]
[0085] The linear equation curve of revenaxin is as follows Fig.13 As shown, the test results and the linear equation are shown in Table 7:
[0086] Table 7 Test results and linear equations of refenacin linear solution
[0087]
[0088] The linear equation curve of impurity B is as follows Fig.14 As shown in Table 8, the test results and the linear equation are as follows:
[0089] Table 8 Impurity B linear solution test results and linear equation
[0090]
[0091] According to the test results in Tables 2 to 8, when the concentration of impurity D is 0.0133-0.591 μg / ml, the concentration of impurity F is 0.0131-0.582 μg / ml, the concentration of impurity A is 0.0143-0.637 μg / ml, the concentration of impurity E is 0.0141-0.627 μg / ml, the concentration of impurity C is 0.0136-0.603 μg / ml, the concentration of revenacin is 0.0133-0.591 μg / ml, and the concentration of impurity B is 0.0137
[0092] In the range of ~0.608μg / ml, the concentration and peak area showed a good linear relationship, indicating that the provided method had good linearity.
[0093] Example 3 Accuracy Test
[0094] 1. Detection method: prepare an accuracy solution (100% limit test solution); then use the liquid chromatography detection conditions provided in Example 1 to detect the above accuracy solution, and calculate the recovery rate and relative standard deviation RSD value based on the added amount, background amount and detection results.
[0095] 2. The preparation of each solution is as follows:
[0096] (1) Blank solution: solvent: mobile phase A-mobile phase B (68:32).
[0097] (2) Impurity A stock solution: Take about 10 mg of impurity A, weigh accurately, place in a 100 ml volumetric flask, add 1 ml of methanol to dissolve, dilute to the mark with solvent, shake well, and obtain (100 μg / ml).
[0098] (3) Impurity B stock solution: Take about 10 mg of impurity B, weigh accurately, place in a 100 ml volumetric flask, add 1 ml of methanol to dissolve, dilute to the mark with solvent, shake well, and obtain (100 μg / ml).
[0099] (4) Impurity C stock solution: Take about 10 mg of impurity C, weigh accurately, place in a 100 ml volumetric flask, add 1 ml of methanol to dissolve, dilute to the scale with solvent, shake well, and obtain (100 μg / ml).
[0100] (5) Impurity D stock solution: Take about 10 mg of impurity D, weigh accurately, place in a 100 ml volumetric flask, add 1 ml of methanol to dissolve, dilute to the mark with solvent, shake well, and obtain (100 μg / ml).
[0101] (6) Impurity E stock solution: Take about 10 mg of impurity E, weigh accurately, place in a 100 ml volumetric flask, add 1 ml of methanol to dissolve, dilute to the mark with solvent, shake well, and obtain (100 μg / ml).
[0102] (7) Impurity F stock solution: Take about 10 mg of impurity F, weigh accurately, place in a 100 ml volumetric flask, add 1 ml of methanol to dissolve it and dilute to the scale with solvent, shake well, and obtain (100 μg / ml).
[0103] (8) Accuracy stock solution: Accurately measure 3 ml of each of the 6 impurity stock solutions mentioned above, place them in a 100 ml volumetric flask, add solvent to dilute to the scale, shake well, and the solution is obtained (each 1 ml of solution contains approximately 3 μg of impurity A, impurity B, impurity C, impurity D, impurity E, and impurity F).
[0104] (9) Mixed impurity reference solution: Take 1 ml of the accuracy stock solution and place it in a 10 ml volumetric flask. Add solvent to dilute to the mark and shake well to obtain (each 1 ml of the solution contains approximately 0.3 μg each of impurity A, impurity B, impurity C, impurity D, impurity E and impurity F).
[0105] (10) Test solution: Take this product and inject it directly.
[0106] (11) Control solution: Accurately measure 0.5 ml of the test solution and place it in a 100 ml volumetric flask. Add diluent to dilute to the mark and shake well to obtain (0.3 μg / ml).
[0107] (12) Quantitation limit stock solution: Accurately measure 3 ml of each of the 6 impurity stock solutions mentioned above, place them in a 100 ml volumetric flask, add solvent to dilute to the mark, shake well, take 1 ml and place it in a 20 ml volumetric flask, add solvent to dilute to the mark, shake well, and the solution is obtained (each 1 ml of solution contains approximately 0.15 μg each of impurity A, impurity B, impurity C, impurity D, impurity E, and impurity F).
[0108] (13) Accuracy solution 1 (4.4% limit): Take 0.9 ml of the quantitative limit stock solution and place it in a 10 ml volumetric flask. Add the test sample and dilute to the mark. Shake well. Prepare 3 portions in the same way (each 1 ml of solution contains approximately 0.0135 μg of impurity A, impurity B, impurity C, impurity D, impurity E, and impurity F).
[0109] (14) Accuracy solution 2 (100% limit): Take 1 ml of the accuracy stock solution and place it in a 10 ml volumetric flask, add the test sample and dilute to the mark, shake well, and the solution is ready. Prepare 3 portions in the same way (each 1 ml of solution contains approximately 0.3 μg of each of impurity A, impurity B, impurity C, impurity D, impurity E, and impurity F).
[0110] (15) Accuracy solution 3 (200% limit): Take 2 ml of the impurity stock solution and place it in a 10 ml volumetric flask, add the test sample and dilute to the mark, shake well, and the solution is ready. Prepare 3 portions in the same way (each 1 ml of solution contains approximately 0.6 μg of each of impurity A, impurity B, impurity C, impurity D, impurity E, and impurity F)
[0111] 3. Calculation formula
[0112]
[0113] 4. Test results
[0114] By testing the above 9 groups of accuracy solutions, the accuracy test results of each impurity are shown in Tables 9 to 14:
[0115] Table 9 Impurity D accuracy test results
[0116]
[0117]
[0118] Table 10 Impurity F accuracy test results
[0119]
[0120] Table 11 Impurity A accuracy test results
[0121]
[0122]
[0123] Table 12 Impurity E accuracy test results
[0124]
[0125] Table 13 Impurity C accuracy test results
[0126]
[0127]
[0128] Table 14 Impurity B accuracy test results
[0129]
[0130] The 9 recovery solutions of each impurity were within the limit range of LOQ to 200%, and the recoveries were all in the range of 80% to 120%. The maximum RSD of the recoveries of the 3 accuracy solutions 1 (limit of quantitation concentration) was 8.9%, which was less than 15%; the maximum RSD of the recoveries of the 3 accuracy solutions 2 (100% limit concentration) was 0.8%, which was less than 10%; the maximum RSD of the recoveries of the 3 accuracy solutions 3 (200% limit concentration) was 5.1%, which was less than 10%. The method had good accuracy.
[0131] Example 4 Impurity detection of refenacin solution for inhalation
[0132] 1. Detection method: The refenacin solution for inhalation (batch number: 2404171-LQ-0h, specification: 3 ml: 175 μg) was detected using the liquid chromatography detection conditions provided in Example 1.
[0133] 2. Preparation of each solution
[0134] (1) Test solution: Take this product and inject it directly.
[0135] (2) Control solution: Accurately measure 0.5 ml of the test solution and place it in a 100 ml volumetric flask. Add solvent to dilute to the mark and shake well.
[0136] (3) System suitability solution: Take appropriate amounts of refenasin, impurity A, impurity B, impurity C, impurity D, impurity E and impurity F, weigh them accurately, place them in a 20 ml volumetric flask, add 1 ml of methanol to dissolve them, dilute to the scale with solvent, shake well to prepare a mixed solution containing approximately 60 μg of refenasin and approximately 0.3 μg each of impurities A, impurity B, impurity C, impurity D, impurity E and impurity F per 1 ml.
[0137] (4) Limits: If there are impurity peaks in the chromatogram of the test solution, the corrected peak areas of impurities A and F (multiplied by the correction factors of 1.3 and 1.5, respectively) shall not be greater than the main peak area of the control solution (0.5%), the peak areas of impurities B, C, D and E shall not be greater than the main peak area of the control solution (0.5%), and the peak areas of other individual impurities shall not be greater than the main peak area of the control solution (0.5%). The sum of the peak areas of the impurities calculated based on the corrected peak areas shall not be greater than 5 times the main peak area of the control solution (2.5%).
[0138] 3. Test results: A batch of refenacin solution for inhalation was tested for related substances. The test results are as follows:
[0139] Table 15 Test results of a batch of refenacin solution samples for inhalation
[0140]
[0141] The above-described embodiments are only preferred embodiments for fully illustrating the present invention, and the protection scope of the present invention is not limited thereto. Equivalent substitutions or changes made by those skilled in the art based on the present invention are within the protection scope of the present invention. The protection scope of the present invention shall be subject to the claims.
Claims
1. A method for simultaneously detecting multiple impurities in a refenacin solution for inhalation, characterized in that: Using liquid chromatography to detect impurities A, B, C, D, E and F in the refenacin solution for inhalation; The structural formulas of the impurities are as follows: The liquid chromatography detection conditions are as follows: the chromatographic column is Agilent EC-C18, 4.6×100 mm, 2.7 μm; the mobile phase A is a phosphate buffer solution of 0.02 mol / l, and the mobile phase B is a mixed solution of acetonitrile-methanol with a volume ratio of 90:10; the flow rate is 1.0 ml per minute; the injection volume is 50 μl; the detection wavelength is 205 nm; the column temperature is 30°C; and the linear gradient elution is performed according to the following table:
2. The method for simultaneously detecting multiple impurities in a refenacin solution for inhalation according to claim 1, characterized in that: The preparation method of the mobile phase A 0.02 mol / l phosphate buffer solution is as follows: 2.72 g of potassium dihydrogen phosphate and 9.2 g of potassium hexafluorophosphate are dissolved in water and diluted to 1000 ml, and the pH value is adjusted to 5.0 with potassium hydroxide solution.
3. The method for simultaneously detecting multiple impurities in a refenacin solution for inhalation according to claim 1, characterized in that: Test solution: Take this product and inject it directly; Control solution: Accurately measure 0.5 ml of the test solution, place it in a 100 ml volumetric flask, add solvent to dilute to the scale, shake well, and obtain; The test solution and the control solution are tested using the liquid chromatography test conditions.
